Deferred Tax Assets, Valuation Allowance of NEUROONE MEDICAL TECHNOLOGIES Corp from 31 Dec 2013 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 30 Sep 2025.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Sep 2025 was $20,475,337, a 7.6% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $20,475,337 +$1,447,300 +7.6% 30 Sep 2025 10-K 17 Dec 2025 2025 FY
Q4 2024 $19,028,037 +$3,600,129 +23% 30 Dec 2024 10-K 17 Dec 2024 2024 FY
Q3 2024 $19,028,037 30 Sep 2024 10-K 17 Dec 2025 2025 FY
Q4 2023 $15,427,908 +$3,510,364 +29% 30 Dec 2023 10-K 17 Dec 2024 2024 FY
Q4 2022 $11,917,544 30 Dec 2022 10-K 15 Dec 2023 2023 FY
Q3 2022 $11,917,544 +$3,109,215 +35% 30 Sep 2022 10-K 22 Dec 2022 2022 FY
Q3 2021 $8,808,329 +$3,113,755 +55% 30 Sep 2021 10-K 22 Dec 2022 2022 FY
Q3 2020 $5,694,574 +$1,743,366 +44% 30 Sep 2020 10-K/A 31 May 2022 2021 FY
Q3 2019 $3,951,208 +$1,835,940 +87% 30 Sep 2019 10-K 09 Dec 2020 2020 FY
Q3 2018 $2,115,268 30 Sep 2018 10-K 20 Dec 2019 2019 FY
Q4 2017 $1,105,877 +$999,845 +943% 31 Dec 2017 10-KT 18 Mar 2019 2018 FY
Q4 2016 $106,032 +$43,015 +68% 31 Dec 2016 10-K 16 Apr 2018 2017 FY
Q4 2015 $63,017 +$17,315 +38% 31 Dec 2015 10-K 17 Apr 2017 2016 FY
Q4 2014 $45,702 +$14,135 +45% 31 Dec 2014 10-K 14 Apr 2016 2015 FY
Q4 2013 $31,567 31 Dec 2013 10-K 15 Apr 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.